With Pfizer’s stock down sharply, an activist investor is pushing for something new from the CEO who spurred the company to ...

Pfizer (PFE) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock. Over ...

The new offer is for a 31% general wage increase over five years instead of the previous offer's 26% increase over four years ...

CVS Health CEO Karen Lynch has stepped down with company shares down 19% this year and the national drugstore chain struggling. Lynch will be replaced by David Joyner, who will attempt to steer ...

Prothena Corporation plc's stock has dropped 67% since my last “Buy” rating, primarily due to delays and a lack of meaningful ...

Treatment-Resistant Depression Treatment MarketThere’s promising news for those struggling with Treatment-Resistant ...

Pfizer Ltd. key Products/Revenue Segments include Pharmaceuticals, Sale of services, Scrap for the year ending 31-Mar-2024.For the quarter ended 30-06-2024, the company has reported a Standalone Total ...